|
gptkb:Baloxavir_marboxil
|
high oral bioavailability
|
|
gptkb:Ribavirin
|
oral bioavailability 45% to 65%
|
|
gptkb:Lariam
|
antimalarial activity
|
|
gptkb:Darunavir
|
half-life of 15 hours
|
|
gptkb:Humira
|
modulates immune response
|
|
gptkb:Reblozyl
|
modulates TGF-beta superfamily signaling
|
|
gptkb:Janumet_50/1000
|
excreted in urine
|
|
gptkb:Entocort
|
high first-pass metabolism
|
|
gptkb:peramivir
|
rapid distribution
|
|
gptkb:paliperidone_palmitate
|
dopamine D2 receptor antagonist
|
|
gptkb:quinidine
|
highly protein-bound
|
|
gptkb:tildrakizumab
|
long half-life
|
|
gptkb:Neupogen
|
half-life of 3.5 hours
|
|
gptkb:Pexeva
|
half-life 24 hours
|
|
gptkb:Advil_Suspension
|
metabolized in liver
|
|
gptkb:Movantik
|
Opioid receptor antagonist
|
|
gptkb:Iclusig
|
metabolized by liver
|
|
gptkb:capecitabine
|
time to peak concentration
|
|
gptkb:Revlimid
|
half-life 3-5 hours
|
|
gptkb:Tirzepatide
|
half-life of approximately 5 days
|